Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Ahn

Showing results (581-590 of 616) with videos related to

Pageof 62
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 28, 2015
A randomized phase II study of the MEK1/MEK2 inhibitor trametinib (GSK1120212) compared with docetaxel in KRAS-mutant advanced non-small-cell lung cancer (NSCLC)†G R Blumenschein, E F Smit, D Planchard, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 11, 2019
Afatinib versus methotrexate as second-line treatment in Asian patients with recurrent or metastatic squamous cell carcinoma of the head and neck progressing on or after platinum-based therapy (LUX-Head & Neck 3): an open-label, randomised phase III trialY Guo, M-J Ahn, A Chan, et al.
Blood|October 2, 2019
Donor cell engineering with GSK3 inhibitor-loaded nanoparticles enhances engraftment after in utero transplantationStavros P Loukogeorgakis, Camila G Fachin, Andre I B S Dias, et al.
ESMO Open|August 30, 2024
A phase II study of tepotinib in patients with advanced solid cancers harboring MET exon 14 skipping mutations or amplification (KCSG AL19-17)E J Kang, Y Yang, S Lee, et al.
Journal of Pediatric Urology|June 9, 2026
Establishing a clinician-prioritized pediatric urology clinical research agenda in the United StatesLauren E Corona, Courtney S Streur, Jennifer J Ahn, et al.
JB & JS Open Access|December 15, 2022
Acute Lower Extremity Fracture Management in Chronic Spinal Cord Injury: 2022 Delphi Consensus RecommendationsL D Carbone, J Ahn, R A Adler, et al.
Journal of Inherited Metabolic Disease|October 17, 2023
Datamining approaches for examining the low prevalence of N-acetylglutamate synthase deficiency and understanding transcriptional regulation of urea cycle genesLjubica Caldovic, Julie J Ahn, Jacklyn Andricovic, et al.
Mucosal Immunology|January 19, 2018
The cytosolic sensor STING is required for intestinal homeostasis and control of inflammationM C C Canesso, L Lemos, T C Neves, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 25, 2014
A randomized phase III trial of stereotactic radiosurgery (SRS) versus observation for patients with asymptomatic cerebral oligo-metastases in non-small-cell lung cancerS H Lim, J Y Lee, M-Y Lee, et al.
Research Square|April 21, 2021
Medical Care Disruptions During the First Six-Months of the COVID19 Pandemic: The Experience of Older Breast Cancer SurvivorsA Dilawari, K E Rentscher, W Zhai, et al.
Pageof 62

Showing results (581-590 of 616) with videos related to

Sort By:
Pageof 62
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 28, 2015
A randomized phase II study of the MEK1/MEK2 inhibitor trametinib (GSK1120212) compared with docetaxel in KRAS-mutant advanced non-small-cell lung cancer (NSCLC)†G R Blumenschein, E F Smit, D Planchard, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 11, 2019
Afatinib versus methotrexate as second-line treatment in Asian patients with recurrent or metastatic squamous cell carcinoma of the head and neck progressing on or after platinum-based therapy (LUX-Head & Neck 3): an open-label, randomised phase III trialY Guo, M-J Ahn, A Chan, et al.
Blood|October 2, 2019
Donor cell engineering with GSK3 inhibitor-loaded nanoparticles enhances engraftment after in utero transplantationStavros P Loukogeorgakis, Camila G Fachin, Andre I B S Dias, et al.
ESMO Open|August 30, 2024
A phase II study of tepotinib in patients with advanced solid cancers harboring MET exon 14 skipping mutations or amplification (KCSG AL19-17)E J Kang, Y Yang, S Lee, et al.
Journal of Pediatric Urology|June 9, 2026
Establishing a clinician-prioritized pediatric urology clinical research agenda in the United StatesLauren E Corona, Courtney S Streur, Jennifer J Ahn, et al.
JB & JS Open Access|December 15, 2022
Acute Lower Extremity Fracture Management in Chronic Spinal Cord Injury: 2022 Delphi Consensus RecommendationsL D Carbone, J Ahn, R A Adler, et al.
Journal of Inherited Metabolic Disease|October 17, 2023
Datamining approaches for examining the low prevalence of N-acetylglutamate synthase deficiency and understanding transcriptional regulation of urea cycle genesLjubica Caldovic, Julie J Ahn, Jacklyn Andricovic, et al.
Mucosal Immunology|January 19, 2018
The cytosolic sensor STING is required for intestinal homeostasis and control of inflammationM C C Canesso, L Lemos, T C Neves, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 25, 2014
A randomized phase III trial of stereotactic radiosurgery (SRS) versus observation for patients with asymptomatic cerebral oligo-metastases in non-small-cell lung cancerS H Lim, J Y Lee, M-Y Lee, et al.
Research Square|April 21, 2021
Medical Care Disruptions During the First Six-Months of the COVID19 Pandemic: The Experience of Older Breast Cancer SurvivorsA Dilawari, K E Rentscher, W Zhai, et al.
Pageof 62